Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study of Safety and Efficacy of an Oral Contraceptive

ClinicalTrials.gov ID: NCT00932321

Public ClinicalTrials.gov record NCT00932321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 7:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open Label, Randomized, Comparator-Controlled Study of the Contraceptive Efficacy of Norethindrone Acetate (NA) and Ethinyl Estradiol (EE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding of norethindrone acetate/ethinyl estradiol (NETA/EE) administered for 24 days and NETA/EE administered for 21 days; and to assess the safety and tolerability of the product.

Study identification

NCT ID
NCT00932321
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
938 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2004 (Type not available)
Primary completion
Nov 2004 (Actual)
Completion
Nov 2004 (Actual)
Last update posted
Apr 22, 2013

2004

United States locations

U.S. sites
34
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Warner Chilcott Investigational Site Birmingham Alabama 35233 —
Warner Chilcott Investigational Site Phoenix Arizona 85014 —
Warner Chilcott Investigational Site Phoenix Arizona 85031 —
Warner Chilcott Investigational Site Chico California 95929 —
Warner Chilcott Investigational Site Los Angeles California 90033 —
Warner Chilcott Investigational Site San Diego California 92103 —
Warner Chilcott Investigational Site San Diego California 92108 —
Warner Chilcott Investigational Site Denver Colorado 80202 —
Warner Chilcott Investigational Site Boynton Beach Florida 33437 —
Warner Chilcott Investigational Site Jacksonville Florida 32207 —
Warner Chilcott Investigational Site Miami Florida 33186 —
Warner Chilcott Investigational Site Palm Harbor Florida 34684 —
Warner Chilcott Investigational Site Venice Florida 34285 —
Warner Chilcott Investigational Site West Palm Beach Florida 33409 —
Warner Chilcott Investigational Site Decatur Georgia 30033 —
Warner Chilcott Investigational Site Decatur Georgia 30034 —
Warner Chilcott Investigational Site Powder Springs Georgia 30127 —
Warner Chilcott Investigational Site Roswell Georgia 30075 —
Warner Chilcott Investigational Site Savannah Georgia 31405 —
Warner Chilcott Investigational Site Louisville Kentucky 40202 —
Warner Chilcott Investigational Site Kansas City Missouri 64112 —
Warner Chilcott Investigational Site St Louis Missouri 63117 —
Warner Chilcott Investigational Site New Bern North Carolina 28562 —
Warner Chilcott Investigational Site Winston-Salem North Carolina 27103 —
Warner Chilcott Investigational Site Allentown Pennsylvania 18104 —
Warner Chilcott Investigational Site Philadelphia Pennsylvania 19114 —
Warner Chilcott Investigational Site Pittsburgh Pennsylvania 15206 —
Warner Chilcott Investigational Site Charleston South Carolina 29425 —
Warner Chilcott Investigational Site Greenville South Carolina 29605 —
Warner Chilcott Investigational Site Sandy City Utah 84070 —
Warner Chilcott Investigational Site Norfolk Virginia 23507 —
Warner Chilcott Investigational Site Richmond Virginia 23233 —
Warner Chilcott Investigational Site Virginia Beach Virginia 23456 —
Warner Chilcott Investigational Site Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00932321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2013 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00932321 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →